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hemorrhage (PPH) and to evaluate the safety, efficacy, and outcome of transcatheter arterial
embolization (TAE).
Methods: An emergency PPH rescue system including the 24-hour-available TAE was estab-
lished in 2004. TAE with gelatine sponge particles placed on bilateral uterine or internal iliac
arteries served as the first-line treatment for intractable PPH. Delivery methods, parity, causes
of bleeding, clinical vital signs, coagulopathy, success rate, resumption of menstruation, and
subsequent pregnancy outcome after TAE were recorded.
Results: From the years 2005 to 2013, 301 women experienced PPH, of whom 178 had control-
lable PPH and 123 intractable PPH. Tachycardia and disseminated intravascular coagulation
were significant risk factors for intractable PPH. All of the women with intractable PPH under-
went TAE, and 89 (72.3%) were transferred by ground transport to receive treatment in this
system. The mean travel distance was 15 km  12.5 km. The mean time of order to angiog-
raphy room was 24.9 minutes  14.2 minutes. The mean blood loss before TAE was
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up, 69 (98.6%) recovered menstruation. Twenty-three women tried to get pregnant and 19
(82.6%) of them succeeded, giving birth to 12 full-term live infants.
Conclusion: TAE was safe and effective in treating intractable primary PPH with a high success
rate and preservation of menstruation and fertility.
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Maternal morbidity and mortality have declined in recent
years due to advances in medicine and medical tech-
niques.1 However, obstetric hemorrhage remains one of the
top three causes of death among women.2 Postpartum
hemorrhage (PPH) is a serious complication, accounting for
25% of pregnancy-related deaths.3 PPH occurs after about
4% of vaginal deliveries and 6% of caesarean deliveries.3
PPH is usually unpredictable, with the progression of
bleeding being fast, urgent, and life-threatening. The most
frequent cause of PPH is uterine atony.4 Several methods
are available to manage PPH including the administration of
uterotonic medications such as oxytocin, misoprostol,
prostaglandin F2a, and ergot alkaloids. If medical treat-
ment fails, further aggressive interventions should be
applied. Interventions include balloon tamponade of the
uterine cavity, uterine artery embolization, uterine
compression sutures (B-Lynch technique), clamping of the
uterine vessels, ligation of the internal iliac arteries, and
hysterectomy.3
Most of these aggressive interventions require an
experienced obstetrician and general anaesthesia. Loss
of fertility is a big regret for patients who undergo life-
saving hysterectomy to control intractable PPH. In
Taiwan, the service of delivering babies is open to all
gynecologists and obstetricians. They can choose to offer
this service in their own clinics, which are composed of
only gynecologists, obstetricians, and rotating anesthe-
siologists. Due to the scale of the settings, they always
lack sound back-up teams, medication, and blood prod-
ucts. Encountering intractable PPH can be a disaster for
them.
Transcatheter arterial embolization (TAE) was first used
to treat uncontrollable PPH in 1979 and is recommended as
a technique prior to surgery due to its efficacy and safety.5
TAE can be performed quickly, with only local anesthesia,
to control obstetrical hemorrhages.6,7 It can reduce the
pressure for the doctors treating congestion uterus and
overwhelming bleeding. However, TAE is not considered
routine and tends to serve as a second-line treatment to
control intractable bleeding. For this reason, a large case
series to prove the benefit and outcome of TAE for PPH does
not exist. To improve the outcome of women suffering from
intractable PPH, we tried to set up the idea of making TAE a
first-line rescue approach.
The aim of this study was to assess the risk factors for
intractable and controllable PPH and to evaluate the effi-
cacy outcomes and subsequent fertility after TAE treat-
ment in women with intractable PPH.Cheng H-H, et al., Transcatheter
, outcome, and subsequent ferti
11Patients and methods
In 2004, an emergency 24-hour transfer system including
specialists in emergency medicine, obstetrics and gyne-
cology, and radiology was established in southern Taiwan at
a tertiary medical center. The TAE team including two
doctors, one technician, and one nurse was asked to be on-
call after routine work and to be ready to perform TAE
within 30 minutes. An official announcement was sent
encouraging all member practitioners with delivery services
to transfer emergency patients. The geographical area
included about 7 million people and 850e950 obstetrician/
gynecologists. Primary PPH was defined as PPH within the
first 24 hours after delivery. Patients with amniotic fluid
embolism (nZ 10), hemolysis, elevated liver enzymes, and
low platelet count (nZ 5), or acute fatty liver (nZ 2) were
excluded by retrospective review of individual prenatal
history and clinical course. Embolization was still per-
formed if necessary. The study was approved by the Insti-
tutional Review Board of the hospital. Informed consent of
this invasive procedure was signed before TAE.
Initial management
On receiving a call, the on-duty obstetrician evaluated the
patient by taking a history and then informed the radiolo-
gists to stand by if intractable PPH was favored. Patients
difficult to evaluate over the phone were evaluated on
arrival using a set protocol (Fig. 1) rather than rushing the
patients to TAE. The same protocol was used to evaluate
women already in our hospital suspected of having PPH.
Upon arrival at the hospital, they would be treated as first
priority. Emergency medical staff stablized the vital signs,
while obstetricians palpated the uterus to check for con-
tractions, examined the pelvis, evaluated the vaginal
canal, and massaged the uterus. Abdominal ultrasonogra-
phy was performed to rule out any retained placental tis-
sue. Oxytocin was infused intravenously, followed by
methylergonovine in patients with no history of hyperten-
sion and a misoprostol suppository was inserted into the
patient’s rectum. Controllable PPH was defined as reduced
bleeding at this stage. Blood products, including whole
blood, packed red blood cells, fresh frozen plasma, plate-
lets, or cryoprecipitate were administered based on vital
signs, estimated blood loss, and laboratory data.
Advanced management with TAE
Intractable PPH was defined as bleeding that persisted
after failure of the above conservative methods. TAE wasarterial embolization as first-line rescue in intractable primary
lity, Journal of the Formosan Medical Association (2016), http://
Figure 1 Flow chart of PPH evaluation and management. ICU Z intensive care unit; PPH Z postpartum hemorrhage;
TAE Z transcatheter arterial embolization.
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+ MODELperformed by radiologists, during which, the vital signs
were closely monitored, and blood products were admin-
istered based on vital signs and the previous laboratory
data. Emergency pelvic angiography was performed using a
Fr. 4 straight pigtail (RADIFOCUS OPTITORQUE, TERUMO,
Japan) catheter for pelvic angiography and localization,
and a Fr. 5 Robertson uterine artery catheter (Beacon Tip
Torcon NB Advantage Catheter, Cook, Denmark) for furtherPlease cite this article in press as: Cheng H-H, et al., Transcatheter
postpartum hemorrhage: Assessment, outcome, and subsequent ferti
dx.doi.org/10.1016/j.jfma.2016.06.011superselection of bilateral uterine arteries. Embolization
with gel foam cubes was performed regardless of active
extravasation of contrast medium. Embolization of the
anterior branch of the bilateral internal iliac arteries was
considered when the uterine arteries were difficult to
identify or engage, or if the patient had an extremely poor
hemodynamic status. Follow-up pelvic angiography was
performed to assess the treatment outcomes. A catheterarterial embolization as first-line rescue in intractable primary
lity, Journal of the Formosan Medical Association (2016), http://
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patient stabilized, but for no more than 3 days.
Post-TAE management
Patients were transferred to the intensive care unit (ICU) or
a general ward, depending on clinical severity. Uterotonic
agents were administered intravenously to maintain
adequate uterine contractions. Primary outcome was
defined as decreased bleeding after the first embolization.
Patients who experienced persistent bleeding with unstable
vital signs underwent a secondary embolization or hyster-
ectomy, with the first TAE deemed a failure. Patients
initially transferred to the ICU were transferred to the
general ward only after attaining a stable condition, with
normal sinus rhythm, blood pressure, and adequate urine
output. The catheter sheath was left in place for at least 24
hours after TAE until a secondary TAE was deemed no
longer necessary. The Foley catheter was subsequently
removed, uterotonic agents were changed from intrave-
nous to oral, and the patient was discharged upon recovery.
Data analysis
Factors analyzed included patient age, parity, delivery
method, possible cause of PPH, vital signs, coagulopathy
status, hemoglobin concentration immediately after PPH,Table 1 Characteristics of the patients with controllable or int
Controlla
Total Z
n (%)
Nulliparous 93 (52)
Aged 34 y 74 (42)
Vaginal delivery 118 (66)
Precipitous labor 17
Cesarean delivery 60 (34)
Tachycardia (HR > 100) 89 (50)
Hypotension (SBP < 90 mmHg) 70 (39)
Hemoglobin level on arrival 9.5  2.2
Lowest hemoglobin level during admission 8.7  2.0
DIC 19 (11)
Quantity of units transfused
Whole blood 0.4  2.0
Packed red blood cells 2.7  3.5
Fresh frozen plasma 1.8  6.4
Platelets 3.4  16
Cryoprecipitate 0.1  1.2
Cause of PPH
Uterine atony 120 (67)
Placenta related 23 (13)
Retained placenta 6
Placenta accreta 17
Genital tract laceration 29 (16)
Unknown 6
Maternal death 0
Data are presented as number, number (%), or mean  SD, as approp
DIC Z disseminated intravascular coagulopathy; HR Z heart rate; PP
* Represents statistically significant values.
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amount of blood transfused, transfer time, order to angi-
ography room time, and days in the ICU and in the hospital.
Tachycardia was defined as a heart rate >100 beats/min
and hypotension as systolic blood pressure <90 mmHg after
conservative treatment. Disseminated intravascular coag-
ulation (DIC) was defined as prolonged prothrombin time
and activated partial thromboplastin time, elevated fibrin
degradation products and D-dimer, and reduced platelet
count and plasma fibrinogen. Patients with intractable PPH
were monitored by telephone to assess any delayed com-
plications, menstruation, and pregnancy outcomes.
Differences between groups were analyzed statistically
with SPSS Statistics 17.0 (SPSS Inc., Chicago, IL, USA), using
the c2 and student t test, with p < 0.05 considered to be
statistically significant. Multivariate logistic regression
analysis was performed to determine risk factors for
intractable PPH.Results
Primary PPH
Of the 301 women who experienced PPH from 2005 to 2013,
178 had controllable PPH and 123 intractable PPH. The mean
ages ( standard deviation) of these groups were 32.0ractable PPH.
ble PPH
178
Intractable PPH
Total Z 123
n (%)
p
60 (49) 0.554
46 (37) 0.467
80 (65) 0.822
9 0.498
43 (35) 0.822
111 (90) <0.05*
65 (53) <0.05*
9.4  2.2 0.447
7.9  2.2 0.374
55 (45) <0.05*
1.3  2.7 <0.0001*
6.5  6.2 <0.0001*
6.0  9.2 <0.0001*
.0 12.5  25.4 <0.0001*
0.7  3.0 <0.0001*
70 (57) 0.063
25 (20) 0.085
5
20
16 (13) 0.432
2
0
riate.
H Z postpartum hemorrhage; SBP Z systolic blood pressure.
arterial embolization as first-line rescue in intractable primary
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Table 2 Characteristics of the patients undergoing TAE
(total Z 123)
Hospital-to-hospital transfer, n (%) 89 (72.4)
Distance from transfer institutions
(km; mean  SD, range)
15  12.5, 4.1e50
Time of transfer or occurrence,
n (%)
8:00 AMe4:00 PM 36 (29.2)
4:00 PMe12:00 AM 62 (50.4)
12:00 AMe8:00 AM 25 (20.3)
Estimated blood loss before TAE
(mL; mean  SD, range)
2247.8  1482.5, 900
e11,110
Order-to-angiography-room time
(min; mean  SD, range)
24.9  14.2, 10e69
TAE site, n (%)
Bilateral internal iliac artery 63 (51.2)
Bilateral uterine artery 52 (42.2)
Bilateral uterine and right
internal pudendal artery
1 (0.8)
Right uterine and left internal
iliac artery
2 (1.6)
Stump branch of left uterine
artery
1 (0.8)
Left uterine and right internal
iliac artery
1 (0.8)
Right uterine artery 1 (0.8)
Bilateral uterine artery and
right vaginal branch
1 (0.8)
Right internal pudendal and
cervicovaginal artery
1 (0.8)
Extravasation, n (%) 45 (36.6)
Hysterectomy performed before
TAE, n (%)
8 (6.5)
Hysterectomy required after
TAE, n (%)
2 (1.6)
Second TAE, n (%) 4 (3.2)
ICU admission, n (%) 54 (43.9)
ICU admission d (d,
mean  SD)
3.8  6.1
Total hospitalization
d (d, mean  SD)
7.4  6.5
ICU Z intensive care unit; SD Z standard deviation;
TAE Z transarterial embolization.
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Table 1 shows the characteristics of the patients with
controllable and intractable PPH. Tachycardia, hypotension,
and DIC occurred significantly more frequently in the group
with intractable PPH. Patients with tachycardia were 6.728
times more likely to progress to intractable PPH [95% confi-
dence interval (CI), 3.325e13.614; p < 0.0001], while pa-
tients with DIC were 4.306 times more likely to progress to
intractable PPH (95% CI, 2.277e8.142; p < 0.0001). Parity,
age, delivery method, and cause of PPH did not differ
significantly. A comparison between delivery methods
(vaginal birth vs. cesarean birth) and age in developing PPH,
and vaginal birth and maternal age < 34 years were signifi-
cantly associated with PPH (65.8% vs. 34.2%; 60.1% vs. 39.9%,
both p < 0.0001). Uterine atony was the most frequent
overall factor leading to PPH. Women with intractable PPH
needed significantly more blood transfusions. No patient died
during the study period in either group.
TAE
Table 2 shows the characteristics of the patients who un-
derwent TAE. The characteristics included estimated blood
loss before TAE, order to angiography room time, transfer
time, distance from transfer institutions, vessels embol-
ised, hysterectomy before TAE, failed first TAE, and ICU and
hospital stays. Eighty-nine (72.4%) patients were trans-
ferred a mean distance of 16.5 km  13.1 km from other
institutions, with most arriving between 4:00 PM and
12:00 AM. The estimated blood loss before TAE was
2247.8 mL  1482.5 mL and the mean order to angiography
room time was 24.9 minutes  14.2 minutes. The first TAE
failed with five patients, making the success rate 95.9%
(118/123). One of these five patients underwent a hyster-
ectomy 7 hours after the first TAE due to persistent
bleeding and unstable vital signs. The other four underwent
a second, successful TAE where the bleeding ceased at first
but persistent oozing or bleeding was noted 1 day later.
Most of them presented severe shock status during the first
TAE. The bilateral internal iliac arteries were embolised in
63 of the 123 (51.2%) patients, followed by bilateral uterine
arteries in 52 of the 123 (42.2%) patients. Eight patients
underwent hysterectomies prior to TAE due to failure of the
medical treatment at the transferring hospitals. One pa-
tient underwent a hysterectomy 2 days after TAE due to
endometritis and sepsis. Fifty-four patients were admitted
to the ICU, with a mean ICU stay of 3.8 days  6.1 days. The
mean hospital stay was 7.4 days  6.5 days. There were no
significant complications related to TAE. The characteris-
tics of the patients with successful TAE and failed TAE are
shown in Table 3. No factor related significantly to the
failure of TAE.
Subsequent fertility
We successfully contacted 70 patients (Table 4), excluding
the 10 who had hysterectomies. They mentioned no
delayed complications. Of these patients, 69 (98.6%) had
resumed menstruation. One woman missed her period,
possibly due to Sheehan syndrome. Of the 69 patients, 46
(66.7%) desired no further pregnancy because they werePlease cite this article in press as: Cheng H-H, et al., Transcatheter
postpartum hemorrhage: Assessment, outcome, and subsequent ferti
dx.doi.org/10.1016/j.jfma.2016.06.011multiparas or for another personal reason. Four women said
that their terrible experiences left them with a great
aversion to becoming pregnant again. Twenty-three women
tried to get pregnant, and 19 (82.6%) of them succeeded,
with the shortest interval being 6 months after TAE. Of
these 19 pregnancies, 11 had full-term live births, two
experienced preterm premature rupture of the mem-
branes, one experienced preterm labor, one underwent
early termination due to personal reasons, two had a
missed abortion, one developed an ectopic pregnancy, and
one was currently pregnant. Among the 11 full-term live
births, one neonate had intrauterine growth restriction,
which was recorded as a birth weight of only 2365 g at a
gestational age of 40 weeks. Four (19%) women failed in
getting pregnant and two of these women had a history of
infertility. Two women suffered recurrent PPH, one ofarterial embolization as first-line rescue in intractable primary
lity, Journal of the Formosan Medical Association (2016), http://
Table 3 Characteristics of patients with successful and
failed TAE
Characteristic (n) Successful
Total Z 118
n (%)
Failed
Total Z 5
n (%)
p
Nulliparous (60) 56 (47.5) 4 (80) 0.15
Multiparous (63) 62 (52.5) 1 (20) 0.15
Age 34 y (46) 45 (39) 1 (20) 0.41
<34 y (77) 73 (61) 4 (80) 0.41
Vaginal delivery (80) 78 (66.1) 2 (40) 0.23
Cesarean delivery (43) 40 (33.9) 3 (60) 0.23
Tachycardia (HR > 100)
(111)
106 (89.8) 5 (100) 0.45
Hypotension (SBP < 90
mmHg) (65)
63 (53.4) 2 (40) 0.56
DIC (55) 51 (43.2) 4 (80) 0.11
Cause of PPH
Uterine atony (70) 66 (55.9) 4 (80) 0.29
Retained placenta (25) 25 (21.2) 0 0.25
Genital tract
laceration (16)
15 (12.7) 1 (20) 0.64
Unknown 12 (10.2) 0 0.45
DIC Z disseminated intravascular coagulopathy; HR Z heart
rate; PPH Z postpartum hemorrhage; SBP Z systolic blood
pressure; TAE Z transarterial embolization.
6 H.-H. Cheng et al.
+ MODELwhich was successfully treated with medication and the
other treated with TAE again.Discussion
In this study of 301 women experiencing primary PPH, we
found that the initial TAE had a high success rate of 95.9% in
treating intractable PPH without any mortalities or major
complications. Menstruation resumed in 98.6% of womenTable 4 Follow-up after transcatheter arterial emboliza-
tion (total Z 70)
n (%)
Resumed menstruation
Eumenorrhea 61 (87.1)
Hypomenorrhea 8 (11.4)
Amenorrhea 1 (1.4)
No pregnancy desire 46 (65.7)
Pregnancy desire 23 (32.9)
Tried to get pregnant but failed 2 (8.7)
Tried to get pregnant, had previous
infertility history
2 (8.7)
Pregnancy 19 (82.6)
Term live birth 12 (63.2)
Preterm premature rupture of membrane 2 (10.5)
Termination due to personal reason 1 (5.3)
Missed abortion 2 (10.5)
Ectopic pregnancy 1 (5.3)
Ongoing pregnancy 1 (5.3)
Please cite this article in press as: Cheng H-H, et al., Transcatheter
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resulted in a pregnancy rate of 82.6%.
TAE has limitations for widespread use because of a lack
of high-tech facilities. Therefore, we organized the in-
hospital resources and developed 24-hour availability of
TAE to improve the prognosis of PPH. Lee et al8 reported
the largest case series and the initial success rate was 86.5%
in 251 patients. The high success rate of 95.9% in our study
is probably attributable to the management protocol used
and a well-prepared team controlling the order-to-
angiography-room time within 30 minutes. It also resulted
in no mortalities which might be due to our exclusion of PPH
resulting from amniotic fluid embolism (AFE), acute fatty
liver, or hemolysis, elevated liver enzymes, and low
platelet count. Mortality is more often observed in AFE
which first presents as PPH. In the present series of pa-
tients, 72.4% were transferred from other medical in-
stitutions. Previous studies showed that hospital-to-
hospital transfer did not have a detrimental effect on the
success of TAE.9,10 To save women with serious PPH, a
practical strategy would be to set up a tertiary referral
center with 24-hour availability of TAE services.
The incidence of failed TAE is about 5%.11 In the 2012
report by Lee et al,8 DIC and massive blood transfusion (>10
red blood cell units) were associated with failed TAE. In our
study, nearly half of the patients with intractable PPH
developed DIC. Along with adequate blood supplementa-
tion and close monitoring, TAE still resulted in good out-
comes in the patients with coagulopathy or DIC. The main
cause of TAE failure is vascular spasm due to massive
bleeding leading to shock, impending shock status, or
revascularization.12,13 Cesarean birth was also associated
with a high TAE failure rate.14
The complication rate of TAE is approximately 9% and
includes transient fever, transient buttock or foot ischemia,
abscess, and iliac artery perforation.15 However, there was
no significant complication related to embolization
observed in our study. Yu et al13 suggested that skillful
catheterization, proper location, gentle injection of the
embolizing material, and care in choosing appropriate
vessels helped prevent complications.
The ultimate goal of the emergency TAE program is to
preserve menstruation and fertility. A review of 13 studies
concluded that TAE indeed preserved menstruation and
fertility. In addition, it was associated with good pregnancy
outcomes, and the use of the gelatine sponge had the po-
tential for recanalization up to 3 weeks later.16 Three
previous studies also reported that women who undergo
TAE can expect normal menstruation and successful future
pregnancies.17e19 Fiori et al19 suggested that TAE does not
impair the endometrial or ovarian function. Success rates of
100% have been reported among women who desired
another pregnancy after TAE.20 We found recovery of
menstruation in 98.6% of the women, with only one woman
developing Sheehan syndrome. For women trying to
become pregnant 82.6% of them succeeded, with the
shortest interval of 6 months and only two miscarriages.
Four women, however, exhorted that the experience of
PPH reduced their desire to become pregnant again, indi-
cating that psychological trauma should be considered
when assessing the subsequent potential of becoming
pregnant after PPH.arterial embolization as first-line rescue in intractable primary
lity, Journal of the Formosan Medical Association (2016), http://
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zation on future pregnancy, we encountered three preterm
pregnancies and one case of fetal growth restriction. It is
uncertain whether these difficulties are connected with
TAE. Delotte et al16 reviewed 32 live births and encoun-
tered two cases of growth restrictions (6%) and two preterm
births (6%). They concluded that the etiology remained
unknown. Chauleur et al20 agreed that arterial emboliza-
tion used in treating PPH does not increase adverse preg-
nancy outcomes.
It is crucial to identify the severity of PPH and to
determine the timing for TAE. Persistent tachycardia
frequently occurs after conservative treatment, and DIC
occurs significantly more often in patients with intractable
PPH. These two adverse events herald the best time to
switch from medical treatment to TAE. Massive PPH re-
duces venous return, with a compensatory increase in heart
rate. This is followed by a reduction in blood pressure if no
further increase in heart rate is possible.21
The risk factors for PPH occurrence included vaginal
delivery and age <34 years, although a previous study re-
ported that caesarean delivery carries a higher risk of
PPH.22 The most frequent cause of PPH was uterine atony,
in which the uterus fails to contract for hemostasis. Other
common causes were retained placental tissue and
placenta accreta, the latter of which is reported to
contribute to adverse maternal complications, including
haemorrhage.23,24
There are several limitations to this study. First, it was a
retrospective analysis. Second, we lacked data on the
course and duration of labor before PPH because most pa-
tients were transferred from other hospitals. Thus, it was
difficult to have all possible risk factors for PPH for the
analysis. In addition, the amount of blood lost could not be
accurately calculated because the hemorrhaging was too
rapid and urgent. The severity of obstetrical bleeding is
always underestimated.
TAE as first-line rescue for intractable PPH could be
practical if there is sufficient time to arrange it. With this
timely intervention, bleeding could be controlled effec-
tively to improve maternal morbidity and mortality.
Menstruation and fertility could be preserved successfully
for future pregnancy.Acknowledgments
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